Dr. Ravi Salgia
Claim this profileCity of Hope Medical Center
Studies Skin Cancer
Studies Non-Small Cell Lung Cancer
4 reported clinical trials
10 drugs studied
Area of expertise
1Skin Cancer
Stage IV
KRAS positive
2Non-Small Cell Lung Cancer
Stage IV
KRAS positive
EGFR positive
Affiliated Hospitals
Clinical Trials Ravi Salgia is currently running
Carfilzomib + Sotorasib
for Lung Cancer
This phase I trial tests the safety, side effects, and best dose of carfilzomib in combination with sotorasib in treating patients with KRAS G12C-mutated non-small cell lung cancer (NSCLC) that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts of the body (advanced) or that has spread from where it first started (primary site) to other places in the body (metastatic). Carfilzomib is a drug that binds to and inhibits the activity of the protein complex that is responsible for degrading other damaged or unneeded proteins. The inhibition of this protein by carfilzomib can then cause tumor growth inhibition and cell death. Sotorasib is a drug that binds to and inhibits the activity of the KRAS G12C mutant. This may inhibit growth in KRAS G12C-expressing tumor cells. Combining carfilzomib and sotorasib may be a safe and effective treatment option for patients with KRAS G12C-mutated advanced or metastatic NSCLC.
Recruiting1 award Phase 1
SHP2 Inhibitor
for Solid Cancers
This trial is testing a new drug called HBI-2376 in patients with advanced solid tumors that have specific genetic changes. The drug aims to block a protein that helps cancer cells grow, potentially stopping or slowing down the cancer.
Recruiting1 award Phase 17 criteria
More about Ravi Salgia
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 3 Active Clinical TrialsTreatments Ravi Salgia has experience with
- Carfilzomib
- Sotorasib
- Bosentan
- Gemcitabine
- Nab-paclitaxel
- Atezolizumab
Breakdown of trials Ravi Salgia has run
Skin Cancer
Non-Small Cell Lung Cancer
Lung Cancer
Small Cell Lung Cancer
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Ravi Salgia specialize in?
Ravi Salgia focuses on Skin Cancer and Non-Small Cell Lung Cancer. In particular, much of their work with Skin Cancer has involved Stage IV patients, or patients who are KRAS positive.
Is Ravi Salgia currently recruiting for clinical trials?
Yes, Ravi Salgia is currently recruiting for 3 clinical trials in Duarte California. If you're interested in participating, you should apply.
Are there any treatments that Ravi Salgia has studied deeply?
Yes, Ravi Salgia has studied treatments such as Carfilzomib, Sotorasib, Bosentan.
What is the best way to schedule an appointment with Ravi Salgia?
Apply for one of the trials that Ravi Salgia is conducting.
What is the office address of Ravi Salgia?
The office of Ravi Salgia is located at: City of Hope Medical Center, Duarte, California 91010 United States. This is the address for their practice at the City of Hope Medical Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.